Rates have remained low throughout the pandemic, and appear to be the consequence of measures to curb COVID-19 transmission. The same public health strategies could be used to help reduce antibiotic overprescribing in the future, investigators conclude.
Older adults who received the flu vaccine that season were notably less protected than their younger cohort against acute respiratory symptoms. Vaccination also was more protective against influenza-associated death than it was against nonfatal illness, the researchers found.
Patients of female physicians are vaccinated at higher rates than those of male physicians across patient gender, race and ethnic categories, a large Medicare analysis reveals.
Fully one third of patients with COVID-19 go on to develop substantial neurological and psychiatric problems, including anxiety disorder, dementia, and stroke, a new study finds. Investigators foresee a growing need for clinical services and care for these patients.
People who received a flu vaccination were 24% less likely to test positive for COVID-19. And those who did contract the disease had a less severe course when compared with people who didn’t get a flu shot, investigators say.
Overall seasonal flu activity has remained at lower-than-usual levels in the United States and globally.
Hospitalized influenza patients who were given oseltamivir soon after diagnosis were less likely to be readmitted within 30 days and had shorter lengths of stay than their peers.
Older adults often face persistent functional decline after being hospitalized with influenza. The findings highlight the need for prevention, investigators say.
November flu rates lower than in 2019, pharmacy giant says … NIH: Older women with common breast cancer may not require chemotherapy … Peripheral neuropathy linked to higher mortality risk … Alzheimer’s blood test predicts future cognitive decline in healthy adults … Men with COVID are 3 times more likely to need intensive care: worldwide…
The Food and Drug Administration has expanded the use of the antiviral drug Xofluza (baloxavir marboxil) for use in preventing influenza after exposure to an ill person.
